On the other hand, among the co-downregulated transcription factors in lung cancer, we focused on RUNX1, histone deacetylase 2 (HDAC2), and peroxisome proliferator-activated receptor gamma (PPARG). This evidence concerns the gene HDAC2 and lung carcinoma.